Replication Medical develops and manufactures a broad portfolio of implantable medical devices based on its proprietary hydrogel platform technology. Headquartered in Cranbury, New Jersey in the United States, Replication Medical is a leader in the design and development of novel, biomimetic hydrogel implants providing ground breaking treatment options in a broad range of markets including spine, orthopedics, neuro, and vascular surgery. Replication Medical has over ten years of learning curve experience with its proprietary, biocompatible shape-memory hydrogel. While Replication Medical has focused on spine surgery related products, the underlying technology is a product engine with the potential to have significant impact on virtually any clinical arena.
Replication Medical markets the EnGuard™ protective cover for spinal blood vessels in the US. Additional products are distributed outside the US including treatments for spinal stenosis (GelFix™), degenerative disc disease (GelStix™/NucleoFix™), and the prevention of epidural fibrosis (GelGuard™). Products in the development pipeline will address unmet needs in spine, orthopedics, neuro, vascular and other therapeutic areas.Quality is a key consideration in the design and development of all Replication Medical products. In keeping with its commitment to quality, the company is FDA registered and ISO 13485 certified. http://www.replicationmedical.com
About the Spinal Market
The Spinal implants and spinal devices market, by technology, includes spinal fusion and fixation, vertebral compression fracture treatment, and motion preservation/non-fusion technologies. On the basis of products, the global spinal implants and spinal devices market is divided into six major segments, namely, thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, vertebral compression fracture treatment devices, motion preservation/non-fusion treatment devices, and spine bone stimulators. Bases on the type of surgery, the global spinal implants and spinal devices market is divided into two segments, namely, open surgery and minimally invasive surgery. The spinal decompression devices market, by type of procedure, covers discectomy, laminotomy/laminectomy, foraminotomy/foraminectomy, facetectomy, and corpectomy procedures.
The Spinal market is expected to reach USD 15.73 Billion by 2020, growing at a CAGR of 5.6% from 2015 to 2020. As of 2015, North America is estimated to hold the largest share of the global spinal implants and spinal devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2% from 2015 to 2020. A number of factors, including rising healthcare expenditure in developing nations owing to growing income levels, increasing government funding, presence of a large patient population, rising obesity cases, and growing awareness on the newly developed spine treatment techniques and devices are propelling the growth of the spinal implants and spinal devices market in the Asia-Pacific region. However, challenges associated with this market, such as scarcity of expertise and trained healthcare workers and lack of adequate patient awareness restricts the market growth in this region.
Source: marketsandmarkets.com